======= NCK2 ======= == Gene Information == * **Official Symbol**: NCK2 * **Official Name**: NCK adaptor protein 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8440|8440]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43639|O43639]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NCK2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NCK2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604930|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Adapter protein which associates with tyrosine- phosphorylated growth factor receptors or their cellular substrates. Maintains low levels of EIF2S1 phosphorylation by promoting its dephosphorylation by PP1. Plays a role in ELK1- dependent transcriptional activation in response to activated Ras signaling. {ECO:0000269|PubMed:10026169, ECO:0000269|PubMed:16835242}. |SH3 2| |SH3 1| |SH2| |positive regulation of translation in response to endoplasmic reticulum stress| |negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress| |negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation| |negative regulation of PERK-mediated unfolded protein response| |positive regulation of translation in response to stress| |regulation of translation in response to endoplasmic reticulum stress| |signal complex assembly| |positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway| |regulation of PERK-mediated unfolded protein response| |negative regulation of endoplasmic reticulum unfolded protein response| |negative regulation of transcription from RNA polymerase II promoter in response to stress| |cytoskeletal adaptor activity| |immunological synapse formation| |regulation of translation in response to stress| |receptor signaling complex adaptor activity| |regulation of endoplasmic reticulum unfolded protein response| |negative regulation of peptidyl-serine phosphorylation| |regulation of epidermal growth factor-activated receptor activity| |dendritic spine development| |vesicle membrane| |regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway| |lamellipodium assembly| |positive regulation of response to endoplasmic reticulum stress| |phosphotyrosine residue binding| |lamellipodium organization| |negative regulation of response to endoplasmic reticulum stress| |epidermal growth factor receptor signaling pathway| |SH3/SH2 adaptor activity| |positive regulation of intrinsic apoptotic signaling pathway| |scaffold protein binding| |vascular endothelial growth factor receptor signaling pathway| |cell-cell recognition| |ERBB signaling pathway| |regulation of translational initiation| |regulation of epidermal growth factor receptor signaling pathway| |regulation of response to endoplasmic reticulum stress| |ephrin receptor signaling pathway| |regulation of protein tyrosine kinase activity| |regulation of ERBB signaling pathway| |positive regulation of actin filament polymerization| |positive regulation of T cell proliferation| |dendrite development| |regulation of transcription from RNA polymerase II promoter in response to stress| |regulation of DNA-templated transcription in response to stress| |positive regulation of translation| |positive regulation of protein polymerization| |positive regulation of lymphocyte proliferation| |positive regulation of mononuclear cell proliferation| |positive regulation of leukocyte proliferation| |regulation of peptidyl-serine phosphorylation| |positive regulation of cellular amide metabolic process| |regulation of T cell proliferation| |regulation of intrinsic apoptotic signaling pathway| |regulation of actin filament polymerization| |regulation of signaling receptor activity| |positive regulation of apoptotic signaling pathway| |regulation of actin polymerization or depolymerization| |regulation of actin filament length| |positive regulation of supramolecular fiber organization| |positive regulation of T cell activation| |regulation of lymphocyte proliferation| |regulation of mononuclear cell proliferation| |positive regulation of leukocyte cell-cell adhesion| |positive regulation of cytoskeleton organization| |regulation of leukocyte proliferation| |regulation of protein polymerization| |T cell activation| |cell recognition| |actin filament organization| |positive regulation of protein complex assembly| |regulation of peptidyl-tyrosine phosphorylation| |postsynaptic density| |positive regulation of cell-cell adhesion| |response to endoplasmic reticulum stress| |regulation of actin filament organization| |protein-containing complex binding| |regulation of leukocyte cell-cell adhesion| |regulation of T cell activation| |regulation of actin cytoskeleton organization| |regulation of supramolecular fiber organization| |regulation of translation| |positive regulation of lymphocyte activation| |regulation of cellular component size| |lymphocyte activation| |regulation of actin filament-based process| |regulation of apoptotic signaling pathway| |regulation of cell-cell adhesion| |positive regulation of cell adhesion| |regulation of cellular amide metabolic process| |positive regulation of leukocyte activation| |negative regulation of protein phosphorylation| |positive regulation of cell activation| |negative regulation of phosphorylation| |plasma membrane bounded cell projection assembly| |regulation of protein complex assembly| |supramolecular fiber organization| |cell projection assembly| |actin cytoskeleton organization| |transmembrane receptor protein tyrosine kinase signaling pathway| |regulation of lymphocyte activation| |regulation of anatomical structure size| |positive regulation of cellular component biogenesis| |posttranscriptional regulation of gene expression| |regulation of cytoskeleton organization| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |actin filament-based process| |negative regulation of protein modification process| |regulation of leukocyte activation| |positive regulation of organelle organization| |regulation of cell activation| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |neuron projection development| |negative regulation of cell population proliferation| |regulation of cell adhesion| |positive regulation of cell death| |enzyme linked receptor protein signaling pathway| |regulation of cellular response to stress| |regulation of protein kinase activity| |neuron development| |cellular protein-containing complex assembly| |negative regulation of transcription by RNA polymerase II| |regulation of kinase activity| |positive regulation of cell population proliferation| |leukocyte activation| |regulation of cellular component biogenesis| |cell migration| |regulation of transferase activity| |endoplasmic reticulum| |neuron differentiation| |positive regulation of intracellular signal transduction| |negative regulation of cellular protein metabolic process| |cell activation| |cell motility| |localization of cell| |negative regulation of protein metabolic process| |cytoskeleton organization| |plasma membrane bounded cell projection organization| |positive regulation of immune system process| |cell projection organization| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |regulation of organelle organization| |locomotion| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |generation of neurons| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |positive regulation of signal transduction| |regulation of immune system process| |regulation of cell death| |cellular response to stress| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8504 * **Expression level (log2 read counts)**: 3.08 {{:chemogenomics:nalm6 dist.png?nolink |}}